Post

New research · Ophthalmology
Journal of clinical medicine · 18h
ReviewJournal of clinical medicine · 2026

Real-World Outcomes of Switching to Aflibercept 8 mg in Previously Treated Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.

Abdullah Bousamri, Mohammad Kana'an, Faisal Alharbi, Noor Alqudah
Read paper
OphthalmologyReview

Switching to aflibercept 8 mg was linked to reduced retinal thickness in previously treated eyes.

Real-World Outcomes of Switching to Aflibercept 8 mg in Previously Treated Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.

Abdullah Bousamri … Noor Alqudah
Journal of clinical medicine · 2026
Background

Neovascular age-related macular degeneration (nAMD) remains a leading cause of irreversible central vision loss.

Methods

Following PRISMA 2020 guidelines, we searched PubMed, Embase, Web of Science, CENTRAL, Scopus, and Google Scholar through April 2026.

Results

eye scans showed less retinal swelling after switching

WMD -21.50 (95% CI -29.30 to -13.70)
null = 0-29.30-13.70
CI excludes the null - significant
More results

Twenty-one studies met inclusion criteria.

BCVA remained stable (WMD: -0.017 logMAR; 95% CI: -0.027 to -0.007; +0.83 ETDRS letters; I 2 = 0%).

Intraretinal and subretinal fluid each resolved in 37.5% of eyes.

More results

Intraocular inflammation was rare across 9959 treated eyes, though this pool was not restricted to switched eyes, with no confirmed retinal vasculitis.

“
Conclusion · 1 of 2

Low-certainty evidence suggests that switching to aflibercept 8 mg preserves visual acuity, while very-low-certainty evidence suggests reductions in central subfield thickness and modest extension of treatment intervals.

Conclusion · 2 of 2

Intraocular inflammation was rare, though safety denominators included non-switch eyes. These findings provide preliminary pooled estimates to inform switch decisions in previously treated eyes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving